Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis

Cancer Letters

Volumn 284, Issue 2, 2009, Pages 189-197

  Yuan jing, Fan ^a   Nan shan, Huang ^a   Lian, Xia ^b  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^b ANYA Science and Technology Invests Co Ltd   (China)

Author keywords

Apoptosis; Genistein; Prostate cancer; RNA interference; Survivin

Indexed keywords

GENISTEIN; SMALL INTERFERING RNA; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENTIATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; DRUG SCREENING ASSAYS, ANTITUMOR; GENETIC VECTORS; GENISTEIN; HELA CELLS; HEPATOCYTES; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 69549108253     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.04.024     Document Type: Article

References (35)

1. Wuttke W., Jarry H., and Wuttke D.S. Isoflavones-safe food additives or dangerous drugs?. Ageing Research Reviews 6 (2007) 150-188
2. Kazuhiro S., Hidekazu K., Hiroshi M., Yoshihiro O., Masaru H., Haruki N., Hironobu O., et al. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. International Journal of Cancer 99 (2002) 846-852
3. Chang K.L., Cheng H.L., Huang L.W., Hsieh B.S., Hu Y.C., Chih T.T., Shyu H.W., and Su S.J. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Cancer Letters 276 (2009) 14-20
4. Teruki O., Yoshihiro S., Tohru H., Nobumasa T., and Mano H. Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Letters 577 (2004) 55-59
5. Bektic J., Guggenberger R., Eder I.E., Pelzer A.E., Berger A.P., Bartsch G., and Klocker H. Molecular effects of the isoflavonoid genistein in prostate cancer. Clinical Prostate Cancer 4 2 (2005) 24-129
6. Quanri J., David G.M., Li M., Waun K.H., and Ho-Young L. Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis 29 (2008) 1614-1622
7. Trang H., Se′bastien W., and Mouldy S. Transcriptional targeting of small interfering RNAs into cancer cells. Biochemical and Biophysical Research Communications 350 (2006) 854-859
8. Song H., Xiao-Yan X., Xiao F., De-Tang W., Qiao-Hong Y., and Han X. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells. European Journal of Obstetrics & Gynecology and Reproductive Biology 136 (2008) 83-89
9. Asanuma H., Torigoe T., Kamiguchi K., Hirohashi Y., Ohmura T., Hirata K., Sato M., and Sato N. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Research 65 (2005) 11018-11025
10. Michael E.W., David K.H., and Hockenbery D.M. Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells. FEBS Letters 481 (2000) 13-18
11. Trang H., Se'bastien W., and Mouldy S. Transcriptional targeting of small interfering RNAs into cancer cells. Biochemical and Biophysical Research Communications 350 (2006) 854-859
12. Gabrielle G., Milheon C., Lijun T., Sarah F., Kent A.G., Megan K., and Rebecca L. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecologic Oncology 105 (2007) 23-30
13. Karedath A., Gopakumaran R., Nair R., Thankappan R., Mani S., et al. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on breast cancer susceptibility gene-1 (BRCA1) status. European Journal of Pharmacology 588 (2008) 158-164
14. Syed D.N., Khan N., Afaq F., and Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiology Biomarkers & Prevention 16 (2007) 2193-2203
15. Klein E.A. Chemoprevention of prostate cancer. Critical Reviews in Oncology/Hematology 54 (2005) 1-10
16. Kim H., Peterson T.G., and Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor b signaling pathways 1-3. American Journal of Clinical Nutrition 68 (1998) 1418S-1425S
17. Brow A., Jolly P., and Wei H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 19 (1998) 991-997
18. Downward J., Parker P., and Waterfield M.D. Autophosphorylation sites on the epidermal C. growth factor receptor. Nature 311 (1984) 483-485
19. Oda K., Matsuoka Y., Funahashi A., and Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Molecular Systems Biology 25 (2005) 1-17 10.1038/ msb4100014)
20. Chuan, Shirong L., Xia D., Yanqing C., Zhi F., Yun Z., and Jun W. Genistein inhibits proliferation and functions of hypertrophic scar fibroblasts. Burns 35 (2009) 89-97
21. Singh R.P., and Agarwal R. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocrine-related Cancer 13 (2006) 751-778
22. Sarkar F.H., and Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews 21 (2002) 265-280
23. Chulso M., JongChul P., Young Kwang C., Jin Han Y., and Saechul K. Current status of experimental therapeutics for prostate cancer. Cancer Letters 266 (2008) 116-134
24. Huiqing Y., Yunqian P., and Charles Y.F.Y. Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Letters 213 (2004) 155-163
25. Tariq A.B., and Rana P.S. Tumor angiogenesis-a potential target in cancer chemoprevention. Food and Chemical Toxicology 46 (2008) 1334-1345
26. JoydebKumar K., and YoungJoon S. Cancer chemopreventive and therapeutic potential of resveratrol mechanistic perspectives. Cancer Letters 269 (2008) 243-261
27. JingRu W., ChenHsun T., Samuel K.K., and ChingShih C. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Letters 262 (2008) 153-163
28. Dolores J.L., and Lixin Z. Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease Progression. Journal of Nutrition 135 (2005) 3009-3015
29. JinRong Z., Lunyin Y., Ying Z., Rena L.N., Adrian A.F., Sandra M.G., and George L. Blackburn Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. The Prostate 53 2 (2002) 143-153
30. Kindt N., Menzebach A., Wouwer M.V., Betz I., Vriese A.D., and Conway E.M. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB Journal 22 (2008) 510-521
31. Gossner G., Choi M., Tan L., Fogoros S., Griffith K.A., Kuenker M., and Liu J.R. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecologic Oncology 105 (2007) 23-30
32. Young-Ho K., Dae-Hee L., Jae-Hoon J., Zong Sheng G., and Yong J.L. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochemical Pharmacology 75 (2008) 1946-1958
33. Schwab M., Reynders V., Steinhilber D., and Stein J. Combined treatment of Caco-2 cells with butyrate and mesalazine inhibits cell proliferation and reduces survivin protein level. Cancer Letter 273 (2009) 98-106
34. Banerjee S.J., Li Y., Wang Z., and Sarkar F.H. Multi-targeted therapy of cancer by genistein. Cancer Letters 269 (2008) 226-242
35. Yiwei L., and Fazlul H.S. Gene expression profiles of genistein-treated PC3 prostate cancer cells. Journal of Nutritional 132 (2002) 3623-3631